Tagrisso Static HCP Banner Ad: See the New Phase III Head-to-Head Results
![](https://oncedailypharma.com/wp-content/uploads/2018/05/tagrisso-banner-static.jpg)
Brand: Tagrisso (osimertinib), Tablets
Parent Company: AstraZeneca
Drug Type: Prescription
Drug Category: Oncology
Campaign: Post-Launch
Targeting: HCPs
Patient Website: https://www.tagrisso.com/
HCP Website: https://www.tagrissohcp.com/